These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24346925)

  • 1. Propranolol for treatment of infantile hemangiomas.
    Melo JN; Rotter A; Rivitti-Machado MC; Oliveira ZN
    An Bras Dermatol; 2013; 88(6 Suppl 1):220-3. PubMed ID: 24346925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What's new about infantile hemangiomas?].
    Dreyfus I; Maza A; Mazereeuw-Hautier J
    Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
    Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
    Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
    J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy.
    Yeh I; Bruckner AL; Sanchez R; Jeng MR; Newell BD; Frieden IJ
    Pediatr Dermatol; 2011; 28(3):267-75. PubMed ID: 21517953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
    Phillips JD; Zhang H; Wei T; Richter GT
    JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
    Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S
    Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.
    Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J
    Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence rate of infantile hemangioma after oral propranolol therapy.
    Frongia G; Byeon JO; Mehrabi A; Günther P
    Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
    Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
    Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
    de Wild SR; Moyakine AV; van der Vleuten CJM
    Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
    Kardasevic M; Dinarevic SM
    Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
    Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
    Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.